Jan 10, 2020
Concerto HealthAI Announces Expanded Collaboration with Pfizer to Accelerate Real-World Evidence and AI Technologies for Additional Disease Areas
Dec 16, 2019
CancerCare® to Provide Vital Support for Cancer Patients Impacted by the California Wildfires
Dec 10, 2019
Belong.Life Cancer Clinical Trial Matching Feature Surpasses 6,000 Suggested Patient Matches
Nov 20, 2019
Belong.Life Expands to South Africa, Broadens Global Impact
Oct 21, 2019
Concerto HealthAI Research Demonstrates that its Patient Reported Outcomes System Effectively Bridges the Communication Gap between Patients and their Clinical Team
Sep 03, 2019
Concerto HealthAI to Showcase Data Demonstrating Effectiveness of an Electronic Patient Reported Outcomes System at ASCO Quality Care Symposium
Aug 07, 2019
Gregory Gilmore D.O. Joins The Oncology Institute of Hope and Innovation
Jul 01, 2019
Belong.Life Raises $14 Million Series B Round to Accelerate Growth of Global Oncology Solution and Expand Rollout End-to-end Patient Engagement and Health Research Platform
Jun 11, 2019
Gateway for Cancer Research Announces Recipient of 4th Annual Young Investigators Award
Jun 05, 2019
Jeffrey Andrey, M.D. Joins The Oncology Institute of Hope and Innovation
Jun 03, 2019
New Data From the Phase I Study of Birinapant in Combination With Keytruda® Presented at ASCO
Jun 03, 2019
Sierra Holds Analyst & Investor Event for SRA737
Jun 03, 2019
Amgen Announces First Clinical Data Evaluating Novel Investigational KRASG12C Inhibitor AMG 510 At ASCO 2019
Jun 03, 2019
Taiho Oncology and Servier Present LONSURF® (trifluridine and tipiracil) Data at the 2019 ASCO Annual Meeting
Jun 03, 2019
New Data from Oncopeptides Phase 1/2 O-12-M1 Trial Evaluating Melflufen in RRMM Presented at 2019 ASCO Annual Meeting
Jun 03, 2019
Innovent Provides Update on Sintilimab in Combination with CAPOX for First-Line Treatment of Patients with Gastric or Gastroesophageal Junction Carcinoma (GC/GEJC)
Jun 03, 2019
Innovent Provides Update on ctDNA in Predicting Response and Resistance by Anti-PD-1 Therapy in Chinese Relapsed/Refractory Classical Hodgkin Lymphoma
Jun 03, 2019
4D Presents MRx0518 Combination Study at ASCO 2019, Chicago, USA
Jun 02, 2019
Amgen Highlights The Versatility Of The BiTE® Immuno-Oncology Platform In Multiple Tumor Types At ASCO 2019
Jun 01, 2019
Concerto HealthAI to Showcase 1st End-to-End RWD and AI Technology Framework for Life Sciences and RWE Solutions at ASCO 2019